NEW YORK, Sept. 2, 2010 (GLOBE NEWSWIRE) -- Regenicin, Inc. (OTCBB:WDSTD), a clinical-stage biotechnology company, announced today that it will hold a media and investor conference at the NASDAQ MarketSite on Tuesday, September 14, 2010 at 1pm EDT. CEO Randy McCoy, senior executives and board members will be present.
